FS Development Corp. II’s Business Combination with Pardes Biosciences

Goodwin Procter advised Pardes Biosciences, while White & Case advised FS Development Corp. II on the deal.FS Development Corp. II (Nasdaq: FSII), a special purpose acquisition…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now